[go: up one dir, main page]
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF®, a Phase II randomised, double-blind, placebo-controlled, dose-finding study.
Chalmers JD, Shteinberg M, Mall MA, O'Donnell AE, Watz H, Gupta A, Frahm E, Eleftheraki A, Rauch J, Chotirmall SH, Armstrong AW, Eickholz P, Hasegawa N, Sauter W, McShane PJ. Chalmers JD, et al. Among authors: rauch j. Eur Respir J. 2024 Sep 10:2401551. doi: 10.1183/13993003.01551-2024. Online ahead of print. Eur Respir J. 2024. PMID: 39255990
ISR vs De Novo Lesion Treatment During OCT-Guided PCI: Insights From the LightLab Initiative.
Bergmark BA, Golomb M, Kuder JF, Buccola J, Wollmuth J, Lopez J, Rauch J, Chehab BM, Rapoza R, West NEJ, Croce KJ. Bergmark BA, et al. Among authors: rauch j. J Soc Cardiovasc Angiogr Interv. 2023 Aug 12;2(6Part A):101118. doi: 10.1016/j.jscai.2023.101118. eCollection 2023 Nov-Dec. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39129892 Free PMC article.
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial).
Waks AG, Chen EL, Graham N, Frey AM, Almeida K, Attaya V, Ryding C, Abbass I, Fung A, Sussell J, Cortazar P, Harvey C, Leth D, Faggen M, Sinclair N, Walsh J, Tung N, Sinclair S, Lo S, Yardley D, Valero V, Meisel J, Ballinger TJ, Adams S, Carey LA, Rauch JK, Abramson VG, Williams NO, Chen WY, Leone JP, Schumer ST, Tayob N, Tolaney SM. Waks AG, et al. Among authors: rauch jk. JCO Oncol Pract. 2024 Jul 19:OP2400021. doi: 10.1200/OP.24.00021. Online ahead of print. JCO Oncol Pract. 2024. PMID: 39028923
Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors - Individual patient data analysis of ANNEXA-4 and TICH-NOAC.
Siepen BM, Polymeris A, Shoamanesh A, Connolly S, Steiner T, Poli S, Lemmens R, Goeldlin MB, Müller M, Branca M, Rauch J, Meinel T, Kaesmacher J, Z'Graggen W, Arnold M, Fischer U, Peters N, Engelter ST, Lyrer P, Seiffge D. Siepen BM, et al. Among authors: rauch j. Int J Stroke. 2024 Jun;19(5):506-514. doi: 10.1177/17474930241230209. Epub 2024 Mar 8. Int J Stroke. 2024. PMID: 38264861
A dynamic time-to-event model for prediction of acute graft-versus-host disease in patients after allogeneic hematopoietic stem cell transplantation.
Och K, Turki AT, Götz KM, Selzer D, Brossette C, Theobald S, Braun Y, Graf N, Rauch J, Rohm K, Weiler G, Kiefer S, Schwarz U, Eisenberg L, Pfeifer N, Ihle M, Grandjean A, Fix S, Riede C, Rissland J, Smola S, Beelen DW, Kaddu-Mulindwa D, Bittenbring J, Lehr T. Och K, et al. Among authors: rauch j. Cancer Med. 2024 Jan;13(1):e6833. doi: 10.1002/cam4.6833. Epub 2023 Dec 22. Cancer Med. 2024. PMID: 38132807 Free PMC article.
383 results